financetom
Business
financetom
/
Business
/
Catalyst Pharmaceuticals Insider Sold Shares Worth $392,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Catalyst Pharmaceuticals Insider Sold Shares Worth $392,000, According to a Recent SEC Filing
Apr 10, 2024 2:33 PM

05:22 PM EDT, 04/10/2024 (MT Newswires) -- David S Tierney, Director, on April 08, 2024, sold 25,000 shares in Catalyst Pharmaceuticals ( CPRX ) for $392,000. Following the Form 4 filing with the SEC, Tierney has control over a total of 348,874 shares of the company, with 348,874 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1369568/000116169724000194/xslF345X03/form4.xml

Price: 16, Change: +0.12, Percent Change: +0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Correction: Airbnb Beats First-Quarter Views, Offers Muted Second-Quarter Guidance
Correction: Airbnb Beats First-Quarter Views, Offers Muted Second-Quarter Guidance
May 8, 2024
05:22 PM EDT, 05/08/2024 (MT Newswires) -- (Corrects nights and experiences booked figures in third paragraph.) Airbnb's ( ABNB ) first-quarter results surpassed Wall Street's estimates on the back of strong travel demand and the timing of Easter, while the vacation rental company late Wednesday offered a muted outlook for the second quarter. Revenue increased 18% year-over-year to $2.14 billion...
Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing
Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing
May 8, 2024
05:23 PM EDT, 05/08/2024 (MT Newswires) -- Lisa D Earnhardt, Executive Vice President, on May 07, 2024, sold 22,852 shares in Abbott Laboratories ( ABT ) for $2,428,119. Following the Form 4 filing with the SEC, Earnhardt has control over a total of 61,462 shares of the company, with 61,462 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1800/000141588924012624/xslF345X03/form4-05082024_090550.xml Price: 104.92, Change: -0.02,...
Formfactor Insider Sold Shares Worth $656,834, According to a Recent SEC Filing
Formfactor Insider Sold Shares Worth $656,834, According to a Recent SEC Filing
May 8, 2024
05:23 PM EDT, 05/08/2024 (MT Newswires) -- Shai Shahar, CFO, Senior Vice President, Global Finance, on May 06, 2024, sold 11,922 shares in Formfactor ( FORM ) for $656,834. Following the Form 4 filing with the SEC, Shahar has control over a total of 15,669 shares of the company, with 15,669 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1039399/000173306824000009/xslF345X03/wk-form4_1715202129.xml Price: 57.00, Change:...
Exact Sciences Stock Plunges On Q1 Earnings: What You Need To Know
Exact Sciences Stock Plunges On Q1 Earnings: What You Need To Know
May 8, 2024
Exact Sciences Corp ( EXAS ) shares are trading lower in Wednesday’s after-hours session on the heels of the company’s first-quarter results. Here’s a rundown of the report. What Happened: Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $627.355 million, according to Benzinga Pro. The company reported a quarterly loss of 60 cents per share,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved